Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

CD177-mediated nanoparticle targeting of human and mouse neutrophils.

Miettinen HM, Gripentrog JM, Lord CI, Nagy JO.

PLoS One. 2018 Jul 10;13(7):e0200444. doi: 10.1371/journal.pone.0200444. eCollection 2018.

2.

Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.

Maaty WS, Lord CI, Gripentrog JM, Riesselman M, Keren-Aviram G, Liu T, Dratz EA, Bothner B, Jesaitis AJ.

J Biol Chem. 2013 Sep 20;288(38):27042-58. doi: 10.1074/jbc.M113.484113. Epub 2013 Jul 19.

3.

Anionic lipid-induced conformational changes in human phagocyte flavocytochrome b precede assembly and activation of the NADPH oxidase complex.

Taylor RM, Riesselman MH, Lord CI, Gripentrog JM, Jesaitis AJ.

Arch Biochem Biophys. 2012 May;521(1-2):24-31. doi: 10.1016/j.abb.2012.01.018. Epub 2012 Mar 10.

PMID:
22430035
4.

Characterization of surface structure and p47phox SH3 domain-mediated conformational changes for human neutrophil flavocytochrome b.

Taylor RM, Lord CI, Riesselman MH, Gripentrog JM, Leto TL, McPhail LC, Berdichevsky Y, Pick E, Jesaitis AJ.

Biochemistry. 2007 Dec 11;46(49):14291-304. Epub 2007 Nov 16.

PMID:
18004884
5.

Single-step immunoaffinity purification and functional reconstitution of human phagocyte flavocytochrome b.

Lord CI, Riesselman MH, Gripentrog JM, Burritt JB, Jesaitis AJ, Taylor RM.

J Immunol Methods. 2008 Jan 1;329(1-2):201-7. Epub 2007 Oct 31.

PMID:
17996248
6.

C-terminal tail phosphorylation of N-formyl peptide receptor: differential recognition of two neutrophil chemoattractant receptors by monoclonal antibodies NFPR1 and NFPR2.

Riesselman M, Miettinen HM, Gripentrog JM, Lord CI, Mumey B, Dratz EA, Stie J, Taylor RM, Jesaitis AJ.

J Immunol. 2007 Aug 15;179(4):2520-31.

7.

Localization of hCAP-18 on the surface of chemoattractant-stimulated human granulocytes: analysis using two novel hCAP-18-specific monoclonal antibodies.

Stie J, Jesaitis AV, Lord CI, Gripentrog JM, Taylor RM, Burritt JB, Jesaitis AJ.

J Leukoc Biol. 2007 Jul;82(1):161-72. Epub 2007 Mar 30.

PMID:
17400609
8.

Analysis of human phagocyte flavocytochrome b(558) by mass spectrometry.

Taylor RM, Baniulis D, Burritt JB, Gripentrog JM, Lord CI, Riesselman MH, Maaty WS, Bothner BP, Angel TE, Dratz EA, Linton GF, Malech HL, Jesaitis AJ.

J Biol Chem. 2006 Dec 1;281(48):37045-56. Epub 2006 Oct 2.

9.
10.

Cloning, sequence analysis and confirmation of derived gene sequences for three epitope-mapped monoclonal antibodies against human phagocyte flavocytochrome b.

Taylor RM, Maaty WS, Lord CI, Hamilton T, Burritt JB, Bothner B, Jesaitis AJ.

Mol Immunol. 2007 Jan;44(4):625-37. Epub 2006 Mar 23.

PMID:
16563510
11.

Comparative evaluation of three different intramuscular delivery methods for DNA immunization in a nonhuman primate animal model.

Rao SS, Gomez P, Mascola JR, Dang V, Krivulka GR, Yu F, Lord CI, Shen L, Bailer R, Nabel GJ, Letvin NL.

Vaccine. 2006 Jan 16;24(3):367-73. Epub 2005 Aug 9.

PMID:
16194587
12.

Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates.

Santra S, Seaman MS, Xu L, Barouch DH, Lord CI, Lifton MA, Gorgone DA, Beaudry KR, Svehla K, Welcher B, Chakrabarti BK, Huang Y, Yang ZY, Mascola JR, Nabel GJ, Letvin NL.

J Virol. 2005 May;79(10):6516-22.

13.

Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.

Barouch DH, Powers J, Truitt DM, Kishko MG, Arthur JC, Peyerl FW, Kuroda MJ, Gorgone DA, Lifton MA, Lord CI, Hirsch VM, Montefiori DC, Carville A, Mansfield KG, Kunstman KJ, Wolinsky SM, Letvin NL.

Nat Immunol. 2005 Mar;6(3):247-52. Epub 2005 Jan 30.

PMID:
15685174
14.

Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques.

Johnson PR, Schnepp BC, Connell MJ, Rohne D, Robinson S, Krivulka GR, Lord CI, Zinn R, Montefiori DC, Letvin NL, Clark KR.

J Virol. 2005 Jan;79(2):955-65.

15.

Site-specific inhibitors of NADPH oxidase activity and structural probes of flavocytochrome b: characterization of six monoclonal antibodies to the p22phox subunit.

Taylor RM, Burritt JB, Baniulis D, Foubert TR, Lord CI, Dinauer MC, Parkos CA, Jesaitis AJ.

J Immunol. 2004 Dec 15;173(12):7349-57.

16.

Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses.

Santra S, Barouch DH, Korioth-Schmitz B, Lord CI, Krivulka GR, Yu F, Beddall MH, Gorgone DA, Lifton MA, Miura A, Philippon V, Manson K, Markham PD, Parrish J, Kuroda MJ, Schmitz JE, Gelman RS, Shiver JW, Montefiori DC, Panicali D, Letvin NL.

Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11088-93. Epub 2004 Jul 16.

17.

Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions.

Jesaitis AJ, Franklin MJ, Berglund D, Sasaki M, Lord CI, Bleazard JB, Duffy JE, Beyenal H, Lewandowski Z.

J Immunol. 2003 Oct 15;171(8):4329-39.

18.

Functional epitope on human neutrophil flavocytochrome b558.

Burritt JB, Foubert TR, Baniulis D, Lord CI, Taylor RM, Mills JS, Baughan TD, Roos D, Parkos CA, Jesaitis AJ.

J Immunol. 2003 Jun 15;170(12):6082-9.

19.

A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02.

Newberg MH, Kuroda MJ, Charini WA, Miura A, Lord CI, Schmitz JE, Gorgone DA, Lifton MA, Kuus-Reichel K, Letvin NL.

Virology. 2002 Sep 30;301(2):365-73.

20.

Prior vaccination increases the epitopic breadth of the cytotoxic T-lymphocyte response that evolves in rhesus monkeys following a simian-human immunodeficiency virus infection.

Santra S, Barouch DH, Kuroda MJ, Schmitz JE, Krivulka GR, Beaudry K, Lord CI, Lifton MA, Wyatt LS, Moss B, Hirsch VM, Letvin NL.

J Virol. 2002 Jun;76(12):6376-81.

21.

Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys.

Santra S, Schmitz JE, Kuroda MJ, Lifton MA, Nickerson CE, Lord CI, Pal R, Franchini G, Letvin NL.

J Immunol. 2002 Feb 15;168(4):1847-53.

23.

Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys.

Barouch DH, Craiu A, Santra S, Egan MA, Schmitz JE, Kuroda MJ, Fu TM, Nam JH, Wyatt LS, Lifton MA, Krivulka GR, Nickerson CE, Lord CI, Moss B, Lewis MG, Hirsch VM, Shiver JW, Letvin NL.

J Virol. 2001 Mar;75(5):2462-7.

24.

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys.

Barouch DH, Craiu A, Kuroda MJ, Schmitz JE, Zheng XX, Santra S, Frost JD, Krivulka GR, Lifton MA, Crabbs CL, Heidecker G, Perry HC, Davies ME, Xie H, Nickerson CE, Steenbeke TD, Lord CI, Montefiori DC, Strom TB, Shiver JW, Lewis MG, Letvin NL.

Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4192-7.

26.

Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys.

Kuroda MJ, Schmitz JE, Charini WA, Nickerson CE, Lifton MA, Lord CI, Forman MA, Letvin NL.

J Immunol. 1999 May 1;162(9):5127-33.

27.

Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.

Reimann KA, Watson A, Dailey PJ, Lin W, Lord CI, Steenbeke TD, Parker RA, Axthelm MK, Karlsson GB.

Virology. 1999 Mar 30;256(1):15-21.

28.

JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy.

Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL.

Neurology. 1999 Jan 15;52(2):253-60.

PMID:
9932940
29.

Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys.

Kuroda MJ, Schmitz JE, Charini WA, Nickerson CE, Lord CI, Forman MA, Letvin NL.

J Virol. 1999 Feb;73(2):1573-9.

30.

Administration of recombinant human interleukin 12 to chronically SIVmac-infected rhesus monkeys.

Watanabe N, Sypek JP, Mittler S, Reimann KA, Flores-Villanueva P, Voss G, Lord CI, Letvin NL.

AIDS Res Hum Retroviruses. 1998 Mar 20;14(5):393-9.

PMID:
9546798
31.

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination.

Letvin NL, Montefiori DC, Yasutomi Y, Perry HC, Davies ME, Lekutis C, Alroy M, Freed DC, Lord CI, Handt LK, Liu MA, Shiver JW.

Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9378-83.

32.

Disseminated granulomatous disease in a simian immunodeficiency virus- and bacille Calmette-Guèrin-infected rhesus monkey.

Chen ZW, Zhou D, Chalifoux L, Lee-Parritz D, Mansfield K, Lord CI, Letvin NL.

AIDS. 1997 Feb;11(2):266-7. No abstract available.

PMID:
9030386
33.

Persistent infection of macaques with simian-human immunodeficiency viruses.

Li JT, Halloran M, Lord CI, Watson A, Ranchalis J, Fung M, Letvin NL, Sodroski JG.

J Virol. 1995 Nov;69(11):7061-7.

34.

Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis.

Morimoto C, Lord CI, Zhang C, Duke-Cohan JS, Letvin NL, Schlossman SF.

Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9960-4.

35.

An acutely lethal simian immunodeficiency virus stimulates expansion of V beta 7- and V beta 14-expressing T lymphocytes.

Chen ZW, Kou ZC, Shen L, Regan JD, Lord CI, Halloran M, Lee-Parritz D, Fultz PN, Letvin NL.

Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7501-5.

36.

In vivo administration to rhesus monkeys of a CD4-specific monoclonal antibody capable of blocking AIDS virus replication.

Reimann KA, Burkly LC, Burrus B, Waite BC, Lord CI, Letvin NL.

AIDS Res Hum Retroviruses. 1993 Mar;9(3):199-207.

PMID:
8471310
37.

Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.

Yasutomi Y, Reimann KA, Lord CI, Miller MD, Letvin NL.

J Virol. 1993 Mar;67(3):1707-11.

38.
39.

New recombinant HLA-B alleles in a tribe of South American Amerindians indicate rapid evolution of MHC class I loci.

Watkins DI, McAdam SN, Liu X, Strang CR, Milford EL, Levine CG, Garber TL, Dogon AL, Lord CI, Ghim SH, et al.

Nature. 1992 May 28;357(6376):329-33.

PMID:
1589035
40.

Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes.

Hasunuma T, Tsubota H, Watanabe M, Chen ZW, Lord CI, Burkly LC, Daley JF, Letvin NL.

J Immunol. 1992 Mar 15;148(6):1841-6.

PMID:
1371792
41.

Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins.

Li J, Lord CI, Haseltine W, Letvin NL, Sodroski J.

J Acquir Immune Defic Syndr (1988). 1992;5(7):639-46.

PMID:
1613662
42.

Risks of handling HIV.

Letvin NL, Lord CI, King NW, Wyand MS, Myrick KV, Haseltine WA.

Nature. 1991 Feb 14;349(6310):573. No abstract available.

PMID:
2000134
43.

Soluble human CD4 elicits an antibody response in rhesus monkeys that inhibits simian immunodeficiency virus replication.

Watanabe M, Chen ZW, Tsubota H, Lord CI, Levine CG, Letvin NL.

Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):120-4.

44.

The gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques.

Miller MD, Lord CI, Stallard V, Mazzara GP, Letvin NL.

J Immunol. 1990 Jan 1;144(1):122-8.

PMID:
2153161
45.

A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes.

Tsubota H, Lord CI, Watkins DI, Morimoto C, Letvin NL.

J Exp Med. 1989 Apr 1;169(4):1421-34.

46.

Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes.

Kannagi M, Chalifoux LV, Lord CI, Letvin NL.

J Immunol. 1988 Apr 1;140(7):2237-42.

PMID:
2965185
47.

Supplemental Content

Support Center